Atwood & Palmer’s Inovio Pharmaceuticals INO Stock Holding History

Atwood & Palmer’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20	Hold	18	–	–	﹤0.01%	491
2026 Q1	$32	Hold	18	–	–	﹤0.01%	527
2025 Q4	$32	Hold	18	–	–	﹤0.01%	480
2025 Q3	$43	Hold	18	–	–	﹤0.01%	479
2025 Q2	$37	Hold	18	–	–	﹤0.01%	507
2025 Q1	$30	Hold	18	–	–	﹤0.01%	435
2024 Q4	$33	Hold	18	–	–	﹤0.01%	464
2024 Q3	$105	Hold	18	–	–	﹤0.01%	466
2024 Q2	$146	Hold	18	–	–	﹤0.01%	426
2024 Q1	$250	Sell	18 -1	-5%	-$9	﹤0.01%	403
2023 Q4	$115	Hold	19	–	–	﹤0.01%	395
2023 Q3	$88	Hold	19	–	–	﹤0.01%	407
2023 Q2	$101	Hold	19	–	–	﹤0.01%	389
2023 Q1	$185	Hold	19	–	–	﹤0.01%	362
2022 Q4	$351	Hold	19	–	–	﹤0.01%	380
2022 Q3	$0	Hold	19	–	–	﹤0.01%	384
2022 Q2	$0	Hold	19	–	–	﹤0.01%	420
2022 Q1	$1K	Hold	19	–	–	﹤0.01%	435
2021 Q4	$1K	Hold	19	–	–	﹤0.01%	447
2021 Q3	$2K	Hold	19	–	–	﹤0.01%	415
2021 Q2	$2K	Hold	19	–	–	﹤0.01%	402
2021 Q1	$2K	Hold	19	–	–	﹤0.01%	425
2020 Q4	$2K	Hold	19	–	–	﹤0.01%	355
2020 Q3	$3K	Hold	19	–	–	﹤0.01%	307
2020 Q2	$6K	Hold	19	–	–	﹤0.01%	280
2020 Q1	$2K	Hold	19	–	–	﹤0.01%	301
2019 Q4	$1K	Hold	19	–	–	﹤0.01%	288
2019 Q3	$0	Hold	19	–	–	﹤0.01%	311
2019 Q2	$1K	Hold	19	–	–	﹤0.01%	290
2019 Q1	$1K	Hold	19	–	–	﹤0.01%	318
2018 Q4	$1K	Hold	19	–	–	﹤0.01%	310
2018 Q3	$1K	Buy	+19	New	+$1.06K	﹤0.01%	305

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Atwood & Palmer's INO Position: Q2 2026 in Review

Atwood & Palmer held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 18 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #491.

Atwood & Palmer first reported a position in INO in Q3 2018 and has held it in 32 quarters since. The position peaked at $6K in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Atwood & Palmer held 18 shares of Inovio Pharmaceuticals worth $20 as of Q2 2026.
Atwood & Palmer left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #491 holding.
Atwood & Palmer first reported a position in Inovio Pharmaceuticals in Q3 2018 and has held it in 32 quarters since.
Atwood & Palmer's Inovio Pharmaceuticals position peaked at $6K in Q2 2020.
103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.